The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ANI Pharmaceuticals Inc shares valued at $14,905 were sold by Cook Meredith on Aug 13 ’24. At $59.62 per share, Cook Meredith sold 250 shares. The insider’s holdings dropped to 56,988 shares worth approximately $3.2 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Shanmugam Muthusamy sold 2,743 shares, netting a total of over 170,066 in proceeds. Following the sale of shares at $62.00 each, the insider now holds 632,620 shares.
Before that, Shanmugam Muthusamy had sold 22,000 shares from its account. In a trade valued at $1,413,940, the HEAD OF R&D, COO-NOVITIUM OPS traded ANI Pharmaceuticals Inc shares for $64.27 each. Upon closing the transaction, the insider’s holdings decreased to 22,000 shares, worth approximately $36.48 million.
As published in their initiating research note from CapitalOne on March 15, 2024, ANI Pharmaceuticals Inc [ANIP] has been an Overweight and the price target has been revised to $80. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in late August. As of March 01, 2023, Guggenheim has initiated its “Buy” rating for ANIP. Earlier on September 07, 2022, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for ANIP stock.
Analyzing ANIP Stock Performance
During the last five days, there has been a drop of approximately -7.59%. Over the course of the year, ANI Pharmaceuticals Inc shares have jumped approximately 1.83%. Shares of the company reached a 52-week high of $70.81 on 03/25/24 and a 52-week low of $52.53 on 09/11/24. A 50-day SMA is recorded $61.39, while a 200-day SMA reached $61.05. Nevertheless, trading volume fell to 0.53 million shares from 0.66 million shares the previous day.
Support And Resistance Levels for ANI Pharmaceuticals Inc (ANIP)
According to the 24-hour chart, there is a support level at 54.97, which, if violated, would cause prices to drop to 53.80. In the upper region, resistance lies at 56.77. The next price resistance is at 57.40. RSI (Relative Strength Index) is 37.63 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.31, which suggests the price will decrease in the coming days. Percent R is at 69.01%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.
